By making such clinical trial information available, we are:
Informing patients, investigators and healthcare professionals about the clinical research it conducts.
Promoting the distribution of knowledge and minimize the duplication of research effort.
Supporting the publication of full manuscripts in peer-reviewed journals.
Contributing towards transparency and build mutual trust.
With respect to the principles set forth by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the Declaration of Helsinki and applicable regulations, we are informing the public about the designs and results of our clinical trials in a timely and balanced manner, regardless of the outcome. We are committed to register clinical trials, which are sponsored by our company, on the U.S National Institutes of Health´s ClinicalTrials.gov website. In addition, we are posting the designs and findings from clinical trials which are sponsored by us, on further national trial registers as mandated by local requirements.
Merck KGaA, Darmstadt, Germany, its prescription medicines division and its worldwide affiliates are not to be considered sponsors of Investigator Sponsored Trials or trials funded by Independent Medical Grants. The responsibility for registering these trial designs and results resides with the sponsor of the trial.